The Guardian reports on the start of PrEPVacc clinical trial

The Guardian has covered the start of the PrEPVacc clinical trial, with its story ‘Africa steps up fight against HIV with trial of new combination vaccines’. Reporter Samuel Okiror notes that the African-led study is expected to involve 1,600 people over the next three years in Uganda, Tanzania, Mozambique and South Africa.